Publications by authors named "Rachel Holbert"
Article Synopsis
- People who use drugs (PWUD) face significant risks of hepatitis B (HBV) and delta (HDV) viruses, but awareness of these risks is low among both the affected communities and healthcare providers.
- The study utilized surveys and interviews in Philadelphia to uncover barriers to HBV and HDV prevention, diagnosis, and care, revealing confusion over insurance and patient hesitancy as key challenges.
- Findings indicated a widespread lack of knowledge about HBV and HDV, suggesting that educational campaigns should be stigma-free, relatable, and empowering to effectively reach and inform the PWUD community.
The prevalence of hepatitis B and delta viruses (HBV/HDV) among people who use drugs (PWUD) remains largely unknown. In the context of one Philadelphia-based harm reduction organization (HRO), this study aimed to assess HBV/HDV prevalence and facilitate linkage to care. Participants completed a demographic HBV/HDV risk factor survey and were screened for HBV and reflexively for HDV if positive for HBV surface antigen or isolated core antibody.
View Article and Find Full Text PDFThis report describes a public-private partnership supported, in part, by federal 340B funds between a community pharmacy and a harm reduction organization. The partnership provides life-saving health care services within a neighborhood disproportionately affected by substance use, poverty, homelessness, and crime and may serve as a model for other communities in need.
View Article and Find Full Text PDFThe Ci-Dll-B gene is an early regulator of ectodermal development in the ascidian Ciona intestinalis (Imai et al., 2006). Ci-Dll-B is located in a convergently transcribed bigene cluster with a tandem duplicate, Ci-Dll-A.
View Article and Find Full Text PDF